5-cyclopropyl-N,N-dimethylpyrazole-1-sulfonamide结构式
|
常用名 | 5-cyclopropyl-N,N-dimethylpyrazole-1-sulfonamide | 英文名 | 5-cyclopropyl-N,N-dimethylpyrazole-1-sulfonamide |
---|---|---|---|---|
CAS号 | 917899-40-2 | 分子量 | 215.27300 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C8H13N3O2S | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
英文名 | 5-cyclopropyl-N,N-dimethylpyrazole-1-sulfonamide |
---|---|
英文别名 | 更多 |
分子式 | C8H13N3O2S |
---|---|
分子量 | 215.27300 |
精确质量 | 215.07300 |
PSA | 63.58000 |
LogP | 1.49580 |
~74% 5-cyclopropyl-N... 917899-40-2 |
文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2006/136830 A1, 2006 ; Location in patent: Page/Page column 204-205 ; WO 2006/136830 A1 |
5-cyclopropyl-pyrazole-1-sulphonic acid dimethylamide |
1H-Pyrazole-1-sulfonamide,5-cyclopropyl-N,N-dimethyl |